home / stock / cing / cing news


CING News and Press, Cingulate Inc. From 03/13/23

Stock Information

Company Name: Cingulate Inc.
Stock Symbol: CING
Market: NASDAQ
Website: cingulate.com

Menu

CING CING Quote CING Short CING News CING Articles CING Message Board
Get CING Alerts

News, Short Squeeze, Breakout and More Instantly...

CING - Cingulate stock slumps ~15% on commercialization pact for ADHD drug CTx-1301

2023-03-13 09:14:08 ET Cingulate ( NASDAQ: CING ) signed a joint commercialization agreement with Indegene for its lead drug candidate CTx-1301 to treat attention deficit/hyperactivity disorder (ADHD). Cingulate said the agreement spans cross-functional services via a...

CING - The Charles Schwab, Banco Santander, First Republic among major financials premarket losers' pack

2023-03-13 08:57:19 ET First Republic FRC -64% amid woes regarding SVB, Signature collapse . Western Alliance WAL -54% amid woes regarding SVB, Signature collapse . PacWest PACW -40% amid woes regarding SVB, Signature collapse . Euda Health ( EUDA...

CING - Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301

Go-to-Market Solution Provides Full Commercial Support for the First, True Entire Active-Day Medication Designed to treat ADHD Indegene Model Geared for Efficient National Commercial Launch in Multibillion-Dollar ADHD Market KANSAS CITY, Kan. and PRINCETON, N.J., March 13, 2023 (G...

CING - Cingulate GAAP EPS of -$0.41 misses by $0.04

2023-03-10 16:36:27 ET Cingulate press release ( NASDAQ: CING ): Q4 GAAP EPS of -$0.41 misses by $0.04 . As of December 31, 2022, Cingulate had $5.4 million in cash and cash equivalents, as compared to $16.5 million in cash and cash equivalents as of December 31, 2021....

CING - Cingulate Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update

CTx-1301 Phase 3 Adult Dose-Optimization Study Ongoing; Results Expected 3Q 2023 Positive Top-Line Data from CTx-1301 Fed/Fast Study Announced, Full Results Submitted for Presentation at Forthcoming Medical Meeting CTx-1301 Pivotal Phase 3 Trial in Pediatric/Adolescent Patients ...

CING - Best Penny Stocks To Buy? 3 Short Squeeze Stocks To Watch

2023-03-10 13:20:19 ET Whether you’re trading penny stocks or higher-priced shares of larger companies, there’s no denying that new and more frequent trends have come to light. Thanks to the huge move in “Ape stocks” during the pandemic, traders are becoming ...

CING - CZOO and EVOK among mid-day movers

2023-03-10 12:40:14 ET Gainers: Euda ( EUDA ) +94% . Altamira Therapeutics ( CYTO ) +40% . Unicycive ( UNCY ) +37% . Cazoo Group ( CZOO ) +27% . Tenon Medical ( TNON ) +20% . PLAYSTUDIOS ( MYPS ) +19% . Solo Brand...

CING - Cingulate Inc. (NASDAQ: CING) Featured in Coverage of the 35th Annual Roth Conference

Cingulate (NASDAQ: CING) , is a biopharmaceutical company utilizing its proprietary PTR(TM) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions charac...

CING - Range Resources, TEGNA, Ready Capital among premarket losers' pack

TEGNA TGNA -22% after FCC orders hearing for Standard General sale . Mount Rainier Acquisition RNER -15% on FY earnings release . Ready Capital RC -12% on Q4 earnings release . Atlas Lithium ( ATLX ) -11% . Movella ( MVLA ) -10% . Ambrx ...

CING - Building a Penny Stocks Portfolio For Long Term 

3 Tips for Building a Long Term Penny Stock Portfolio Building a penny stocks portfolio can be a smart strategy for investors who are willing to take on a higher level of risk in exchange for the potential for higher returns. While penny stocks can be volatile and risky, they can also off...

Previous 10 Next 10